生物科技LOF(501009)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-123,339,664.93 |
279,016,306.96 |
157,764,897.57 |
-515,528,102.84 |
| 利息合计 |
155,466.71 |
380,208.03 |
207,516.49 |
1,315,580.52 |
| 其中:存款利息收入 |
155,466.71 |
380,208.03 |
207,516.49 |
509,007.12 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
3,704.79 |
| 投资收益合计 |
-61,823,604.06 |
-312,830,944.00 |
-157,266,335.93 |
-203,383,262.54 |
| 其中:股票投资收益 |
-78,051,544.33 |
-342,055,686.87 |
-175,597,893.61 |
-240,703,056.97 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
286,545.42 |
362,034.01 |
83,263.05 |
90,905.22 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
15,941,394.85 |
28,862,708.86 |
18,248,294.63 |
37,228,889.21 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-61,774,601.69 |
591,190,723.78 |
314,723,128.08 |
-313,854,548.51 |
| 其他收入 |
103,074.11 |
276,319.15 |
100,588.93 |
394,127.69 |
| 费用 |
10,434,349.02 |
24,253,096.08 |
12,044,566.54 |
25,827,421.52 |
| 管理人报酬 |
7,950,177.14 |
18,330,709.14 |
9,014,391.37 |
18,895,630.67 |
| 基金托管费 |
1,060,023.65 |
2,444,094.62 |
1,201,918.90 |
2,519,417.35 |
| 销售服务费 |
1,321,572.38 |
3,161,453.00 |
1,619,977.24 |
3,699,785.92 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
102,139.69 |
316,839.32 |
208,279.03 |
709,696.92 |
| 利润总额 |
-133,774,013.95 |
254,763,210.88 |
145,720,331.03 |
-541,355,524.36 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年